With its entry into the 10th state, HCG is now a network of 21 comprehensive cancer centers with 24 hospitals across India and Africa, and 8 daycare centres
Healthcare Global Enterprises Limited (HCG) has announced the strategic acquisition of SRJ CBCC Cancer hospital in Indore. HCG further plans to expand by adding 100 beds and state of art cancer diagnostic and treatment facility within an estimated operational timeline of 2 years. With its entry into the 10th state, HCG is now a network of 21 comprehensive cancer centers with 24 hospitals across India and Africa, and 8 daycare centres.
SRJ CBCC Cancer Hospital is centrally located and is the city’s first comprehensive cancer centre and is currently the market leader in private space. The hospital has 50 cancer care beds and houses LINAC machine. The acquisition also unlocks opportunities for operational scale-up, including the introduction of organ-specific practices and the introduction of next-gen cancer care technologies.
Dr B. S. Ajaikumar, Executive Chairman, Healthcare Global Enterprises said, “This milestone marks our entry into this vibrant healthcare market and underscores our unwavering commitment to delivering world-class cancer care. We believe in the potential of this acquisition to make a meaningful impact on the lives of countless patients and further our mission of ensuring accessible and exceptional cancer care across India. Our team’s commitment and SRJ CBCC Cancer Hospital’s established tradition of excellence make us ready to revolutionise oncology care in Indore and the surrounding areas.”
Raj Gore, CEO, Healthcare Global Enterprises said, “We are thrilled to extend our presence in Madhya Pradesh, the heart of Incredible India. Entering Indore, we aim to find more opportunities to address the critical gap in cancer care in Madhya Pradesh. Our endeavor is to make the most advanced and comprehensive cancer treatment available to patients and provide longer and better quality of life to each patient without having to travel miles for it. We would be extending our network strength of renowned oncologists’ and largest Tumor Board in the country to Indore and Madhya Pradesh. Patient outcome is of paramount importance to us and we ensure that all our clinical and non-clinical resources are channelised and geared towards patient care.”